Stratum Biosciences
New York company whose SkinSync AI platform mines a proprietary biobank of more than 200,000 human skin tissue samples to identify biomarkers and decode skin biology, accelerating discovery of novel dermatology actives and therapeutics for R&D partners.
Headquarters
New York City, USA
Year Founded
2024
Founders
Ross Lane Pearlman (co-founder and CEO), Buu Duong (co-founder and President)
Country
United States
Financial Information
Funding Stage
Seed
Recent Funding
$2M
Funding By
Harvard Business School Alumni Angels of Greater New York, Skin Angels
Core Technology
AI analysis of a proprietary human skin tissue biobank for biomarker discovery
Product Type
AI Platform
Pipeline Stage (Very Important)
Regulatory Status
- IND Filed: No
- FDA/EMA Status: N/A
- Clinical Trial Registration: N/A
- Patents / IP Status: Not disclosed
Partnerships
Pharma Collaborations
R&D partnerships (undisclosed)
Academic / Hospital Tie-ups
Not disclosed
CRO/CDMO Partnerships
None disclosed
Market & Differentiation
Largest proprietary human skin tissue biobank applied to AI-driven dermatology discovery